
Performance-Enhancement Sports Startup Enhanced Set for Public Debut via SPAC Deal
Enhanced, which operates a competition allowing athletes to use performance-enhancing drugs under medical oversight, is merging with a blank-check company to reach public markets with a $1.2 billion valuation.


